Newsroom-Katalog
Zeit | Sysmex Inostics GmbH: Meldungen vom 05.11.2018 |
---|---|
12:11 | Sysmex Inostics OncoBEAM(TM) circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers |